Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023 at 07:35 AM EST
Pfizer's drug helped patients lose weight but also caused nausea and diarrhea.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|